Balsa J A, Botella-Carretero J I, Peromingo R, Zamarrón I, Arrieta F, Muñoz-Malo T, Vázquez C
Department of Endocrinology and Clinical Nutrition, Ramón y Cajal Hospital, Madrid, Spain.
J Endocrinol Invest. 2008 Oct;31(10):845-50. doi: 10.1007/BF03346429.
Secondary hyperparathyroidism (SH) is a frequent metabolic complication of bariatric surgery. Around 70%of patients who undergo biliopancreatic diversion (BPD) have this complication in the long term. The aim of this study was to evaluate the relative influence of vitamin D deficiency and calcium malabsorption in the development of SH in patients who underwent BPD. We reviewed the mean values of PTH throughout the post-operative follow-up and of related biochemical data (25-hydroxyvitamin D, calcium, magnesium) of 121 patients who underwent BPD at our institute from November 1996 to November 2004 (mean follow-up 66 months). Mean PTH correlated negatively with mean 25-hydroxyvitamin D (r=-0.27, p=0.003) and with urinary calcium(r=-0.19, p=0.047), and positively with age (r=0.22, p=0.018). However, a high mean PTH was found in 48.7% patients with mean 25-hydroxyvitamin D >or=30 ng/ml and in 80.0% patients with mean 25-hydroxyvitamin D between 20 and 30 ng/ml. The mean PTH was normal in 5 patients without calcium supplements at present, and progressively increased in parallel to the calcium dose in the rest of patients, although mean 25-hydroxyvitamin D levels were not related to the calcium dose. Our data suggest that individual differences in active and/or passive calcium absorption determine intractable SH after BPD in around half of the patients who have normal levels of 25-hydroxyvitamin D and in 80% of patients with 25-hydroxyvitamin D levels between 20 and 30 ng/ml after BPD, worsening with age.
继发性甲状旁腺功能亢进(SH)是减肥手术常见的代谢并发症。接受胆胰转流术(BPD)的患者中,约70%长期会出现这种并发症。本研究旨在评估维生素D缺乏和钙吸收不良对接受BPD患者SH发生发展的相对影响。我们回顾了1996年11月至2004年11月在我院接受BPD的121例患者术后随访期间甲状旁腺激素(PTH)的平均值以及相关生化数据(25-羟维生素D、钙、镁)。平均PTH与平均25-羟维生素D呈负相关(r = -0.27,p = 0.003),与尿钙呈负相关(r = -0.19,p = 0.047),与年龄呈正相关(r = 0.22,p = 0.018)。然而,在平均25-羟维生素D≥30 ng/ml的患者中,48.7%的患者平均PTH较高;在平均25-羟维生素D在20至30 ng/ml之间的患者中,80.0%的患者平均PTH较高。目前5例未补充钙剂的患者平均PTH正常,其余患者的平均PTH随着钙剂剂量的增加而逐渐升高,尽管平均25-羟维生素D水平与钙剂剂量无关。我们的数据表明,主动和/或被动钙吸收的个体差异决定了约一半25-羟维生素D水平正常的患者以及80%术后25-羟维生素D水平在20至30 ng/ml之间的患者在接受BPD后发生难治性SH,并随年龄增长而加重。